Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 2 Genetic characteristics of the T2DM patients and control groups

From: Association of KCNJ11 rs5219 gene polymorphism with type 2 diabetes mellitus in a population of Syria: a case-control study

Variables

Patients (n = 75)

Controls (n = 63)

OR (95% CI)

P-value

Genotypes

 E/E

29 (38.7%)

18 (28.6%)

Reference

 

 E/K

34 (45.3%)

42 (66.6%)

0.502 (0.239–1.055)

0.067

 K/K

12 (16%)

3 (4.8%)

2.483 (0.615–10.02)

0.192

Dominant model

 E/E

29 (38.7%)

18 (28.6%)

Reference

 

 E/K + K/K

46 (61.3%)

45 (71.4%)

0.634 (0.31–1.3)

0.213

Recessive model

 E/E+ E/K

63 (84%)

60 (95.2%)

Reference

 

 K/K

12 (16%)

3 (4.8%)

3.81 (1.024–14.17)

0.035

Alleles

 E

92 (61.3%)

78 (61.9%)

Reference

 

 K

58 (38.7%)

48 (38.1%)

1.024 (0.629–1.667)

0.923

Back to article page

BMC Medical Genetics

ISSN: 1471-2350

Contact us